E
Y-mAbs Therapeutics, Inc. YMAB
$12.47 $0.403.31%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Revenue 19.93M 23.36M 20.45M 20.75M 20.25M
Total Other Revenue -- -- -- -- --
Total Revenue 19.93M 23.36M 20.45M 20.75M 20.25M
Cost of Revenue 2.15M 2.04M 2.65M 4.65M 2.08M
Gross Profit 17.78M 21.32M 17.81M 16.10M 18.17M
SG&A Expenses 11.59M 11.31M 10.36M 11.43M 11.40M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 26.84M 26.56M 28.20M 27.97M 23.27M
Operating Income -6.91M -3.20M -7.75M -7.22M -3.02M
Income Before Tax -6.47M -793.00K -7.56M -6.12M -6.39M
Income Tax Expenses 160.00K 195.00K 187.00K 179.00K --
Earnings from Continuing Operations -6.63M -988.00K -7.75M -6.30M -6.39M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -6.63M -988.00K -7.75M -6.30M -6.39M
EBIT -6.91M -3.20M -7.75M -7.22M -3.02M
EBITDA -6.75M -3.04M -7.58M -7.00M -2.84M
EPS Basic -0.15 -0.02 -0.18 -0.14 -0.15
Normalized Basic EPS -0.09 -0.01 -0.11 -0.09 -0.03
EPS Diluted -0.15 -0.02 -0.18 -0.14 -0.15
Normalized Diluted EPS -0.09 -0.01 -0.11 -0.09 -0.03
Average Basic Shares Outstanding 43.78M 43.63M 43.62M 43.66M 43.67M
Average Diluted Shares Outstanding 43.78M 43.63M 43.62M 43.66M 43.67M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings